Russia Covid vaccine to be distributed in India by Dr Reddy’s

iNDICA NEWS BUREAU & AGENCIES

India-headquartered global pharmaceutical company Dr Reddy’s Laboratories and the Russian Direct Investment Fund (RDIF) have agreed to cooperate on clinical trials and distribution of Sputnik V Covid-19 vaccine in India, Russia’s sovereign wealth fund revealed in a statement Wednesday.

The Sputnik V vaccine is undergoing clinical trials.

“On regulatory approval in India, RDIF shall supply to Dr Reddy’s 100 million doses of the vaccine. The Sputnik V vaccine, which is based on well-studied human adenoviral vector platform with proven safety, is undergoing clinical trials for the coronavirus pandemic,” said a statement from the fund.

Deliveries could potentially begin in late 2020, subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.

India is among the most severely impacted countries from Covid-19 and we believe our human adenovirus dual vector platform will provide a safe and scientifically validated option to India in the battle against it,” said Kirill Dmitriev, chief executive officer, RDIF.

GV Prasad, co-chairman and managing director of Dr Reddy’s, said the Sputnik V vaccine could provide “a credible option in our fight against Covid-19 in India.”

In a statement, Prasad said: “The phase one and two clinical trials have shown promising results. We will be conducting phase three trials in India to ensure safety and efficacy for the Indian population.”

Sputnik V was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and registered August 11.

Earlier this month Dr VK Paul, a member of the Indian government think tank Niti Aayog, had said that the Russian government has sought India’s help in manufacturing the Sputnik V vaccine and also to conduct Phase-3 trials in the country.

Indian Council of Medical Research director General Balram Bhargava said Tuesday: “Russia has a good history of vaccine manufacturing hence we assume that this vaccine is also good. There is a dialogue going on between the high-level committees of the governments of India and Russia. We are trying to work out its mechanism.”